Publication | Open Access

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicineAdvanced Urothelial CarcinomaImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation Oncology